NIVF vs. PBM, CERO, YMTX, KA, SHPH, ENVB, ADIL, OPGN, HILS, and MGRX
Should you be buying NewGenIvf Group stock or one of its competitors? The main competitors of NewGenIvf Group include Psyence Biomedical (PBM), CERo Therapeutics (CERO), Yumanity Therapeutics (YMTX), Kineta (KA), Shuttle Pharmaceuticals (SHPH), Enveric Biosciences (ENVB), Adial Pharmaceuticals (ADIL), OpGen (OPGN), Hillstream BioPharma (HILS), and Mangoceuticals (MGRX). These companies are all part of the "medical" sector.
NewGenIvf Group (NASDAQ:NIVF) and Psyence Biomedical (NASDAQ:PBM) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their community ranking, dividends, earnings, risk, profitability, media sentiment, analyst recommendations, institutional ownership and valuation.
NewGenIvf Group and Psyence Biomedical both received 0 outperform votes by MarketBeat users.
In the previous week, NewGenIvf Group had 2 more articles in the media than Psyence Biomedical. MarketBeat recorded 3 mentions for NewGenIvf Group and 1 mentions for Psyence Biomedical. Psyence Biomedical's average media sentiment score of 1.00 beat NewGenIvf Group's score of 0.39 indicating that Psyence Biomedical is being referred to more favorably in the news media.
NewGenIvf Group has a beta of -0.03, indicating that its stock price is 103% less volatile than the S&P 500. Comparatively, Psyence Biomedical has a beta of -0.22, indicating that its stock price is 122% less volatile than the S&P 500.
66.2% of NewGenIvf Group shares are owned by institutional investors. Comparatively, 77.4% of Psyence Biomedical shares are owned by institutional investors. 31.8% of NewGenIvf Group shares are owned by insiders. Comparatively, 3.6% of Psyence Biomedical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Summary
NewGenIvf Group beats Psyence Biomedical on 3 of the 5 factors compared between the two stocks.
Get NewGenIvf Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for NIVF and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NIVF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
NewGenIvf Group Competitors List
Related Companies and Tools
